• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Cansino Biolgics Reg H (OP:CASBF)

4.258 UNCHANGED
Streaming Delayed Price Updated: 11:12 AM EST, Feb 24, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 4.258
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 4.258
Today's Range 4.258 - 4.258
52wk Range 3.200 - 6.990
Shares Outstanding N/A
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
CanSinoBIO's Menhycia (R) Secures Expanded Age Indication, Unlock Broader Long-Term Growth Potential
February 24, 2026
From CanSino Biologics Inc
Via ACN Newswire
News headline image
Innovative Vaccine Engine Continues to Drive Growth: CanSinoBIO Enters a New Growth Cycle
August 20, 2025
Via ACN Newswire

Performance

YTD
-4.8%
-4.8%
1 Month
+13.5%
+13.5%
3 Month
-14.8%
-14.8%
6 Month
-28.8%
-28.8%
1 Year
-9.8%
-9.8%

More News

Read More
News headline image
CanSinoBIO Launches its Pneumococcal Vaccine: An Innovative Choice to Safeguard Children's Health
June 20, 2025
Via ACN Newswire
News headline image
Revenue Soars with 137% Year-on-Year Growth, Multiple Products Poised for Launch, CanSinoBIO's Growth Momentum Strong
March 25, 2025
Via ACN Newswire
News headline image
CanSino Receives Another Strong Boost
October 09, 2024
Via ACN Newswire
News headline image
CanSinoBIO Reports Outstanding H1 2024 Performance
August 29, 2024
Via ACN Newswire
News headline image
Week In Review: BeiGene And Bristol-Myers Squibb Close BeiGene-Celgene PD-1 Partnership ↗
August 12, 2023
Via Talk Markets
News headline image
Why Is CanSino Biologics (CASBF) Stock Soaring Today? ↗
November 02, 2022
Via InvestorPlace
News headline image
Week In Review: Fosun Acquires VerImmune Cancer Immunotherapy In $125 Million Deal ↗
May 28, 2022
Via Talk Markets
News headline image
Week In Review: Shanghai Regor To Discover Metabolic Therapies For Lilly In $1.55 Billion Deal ↗
December 11, 2021
Via Talk Markets
News headline image
Week In Review: Zai Lab Raises $750 Million In Private Placement For In-Licensed/Novel Drugs ↗
April 24, 2021
Via Talk Markets

Frequently Asked Questions

Is Cansino Biolgics Reg H publicly traded?
Yes, Cansino Biolgics Reg H is publicly traded.
What exchange does Cansino Biolgics Reg H trade on?
Cansino Biolgics Reg H trades on the OTC Traded
What is the ticker symbol for Cansino Biolgics Reg H?
The ticker symbol for Cansino Biolgics Reg H is CASBF on the OTC Traded
What is the current price of Cansino Biolgics Reg H?
The current price of Cansino Biolgics Reg H is 4.258
When was Cansino Biolgics Reg H last traded?
The last trade of Cansino Biolgics Reg H was at 02/24/26 11:12 AM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap